Consensus G MEDPAR

Equities

GMVDF

KYG394621414

Delayed OTC Markets Other stock markets 15:58:31 10/05/2024 BST			5-day change	1st Jan Change
0.014 ^USD	+7.69%		+16.67%	-35.19%

2023	G Medical Innovations Holdings Ltd announced that it has received $0.5 million in funding	CI
2023	G Medical Innovations Holdings Ltd announced that it expects to receive $0.5 million in funding	CI

Evolution of the average Target Price on G MEDPAR

Price target over the last 5 years

History of analyst recommendation changes

ae706c1b31a49ff0c.UJw4-xgYYNVQMnFCCT6JoLW3XSWhacCkRyrWEFnTHd8.HtdvukhgLeA2ARcnPFHvw_LyFGboOajuI0e5ZAqhU55k9n20eigTlwl2QQ~7fc134c84e7c8b1d99c2934bdc2e1bb7

Analyst Recommendations on G MEDPAR

ThinkEquity Initiates G Medical Innovations at Buy Rating With $4 Price Target	20/06/23	MT
Traders Brace for Fed Rate Decision, Driving Premarket Losses for US Equity Futures	30/01/23	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.013 USD

Average target price

210 USD

Spread / Average Target

+1,615,286.23%

High Price Target

210 USD

Spread / Highest target

+1,615,286.23%

Low Price Target

210 USD

Spread / Lowest Target

+1,615,286.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering G MEDPAR

ThinkEquity

Quarterly revenue - Rate of surprise

Company calendar